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Rhinosporidiosis manifests as slow-growing,
tumorlike masses, usually of the nasal mucosa or
ocular conjunctivae of humans and animals.
Patients with nasal involvement often have
unilateral nasal obstruction or bleeding due to
polyp formation. The diagnosis is established by
observing the characteristic appearance of the
organism in tissue biopsies (Figure 1). Treatment
consists of surgical excision, but relapse occurs in
approximately 10% of patients (1); antimicrobial
therapy is not effective (2). Rhinosporidiosis
occurs in the Americas, Europe, Africa, and Asia
but is most common in the tropics, with the
highest prevalence in southern India and Sri
Lanka. A survey of schoolchildren from Pallam,
India, found 11 cases in 781 children examined
(prevalence 1.4%) (3). Autochthonous cases have
been reported from the southeastern United
States (4). Studies have linked infection to
swimming or bathing in freshwater ponds, lakes,
or rivers (2,5).
The etiologic agent of rhinosporidiosis,
Rhinosporidium seeberi, is an enigmatic microbe
that has been difficult to classify. Recently,
R. seeberi has been considered a fungus, but it was
originally thought to be a protozoan parasite (2).
Its morphologic characteristics resemble those of
Coccidioides immitis: both organisms have
mature stages that consist of large, thick-walled,
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Rhinosporidium seeberi, a microorganism that can infect the mucosal surfaces of
humans and animals, has been classified as a fungus on the basis of morphologic and
histochemical characteristics. Using consensus polymerase chain reaction (PCR), we
amplified a portion of the R. seeberi 18S rRNA gene directly from infected tissue.
Analysis of the aligned sequence and inference of phylogenetic relationships showed
that R. seeberi is a protist from a novel clade of parasites that infect fish and amphibians.
Fluorescence in situ hybridization and R. seeberi-specific PCR showed that this unique
18S rRNA sequence is also present in other tissues infected with R. seeberi. Our data
support the R. seeberi phylogeny recently suggested by another group. R. seeberi is not
a classic fungus, but rather the first known human pathogen from the DRIPs clade, a
novel clade of aquatic protistan parasites (Ichthyosporea).
Figure 1. Histology of rhinosporidiosis. A formalde-
hyde-fixed section of human nasal polyp was stained
with periodic acid-Schiff (PAS) and visualized by
bright-field microscopy at 400X magnification. The
thick walls of immature R. seeberi trophocytes stain
with PAS (pink), and the spherical organisms are
surrounded by inflammatory cells.Resear Resear Resear Resear Research ch ch ch ch
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spherical structures containing smaller daughter
cells (endospores). In addition, R. seeberi is
visualized with fungal stains such as methe-
namine silver and periodic acid-Schiff, as well as
mucicarmine, which stains the fungus Cryptococ-
cus neoformans. R. seeberi has not been detected
in the environment, and its natural host or
reservoir is unknown. Attempts to propagate this
organism on artificial media have failed, as has
continuous cocultivation with human cell lines (6).
We report a molecular approach for estab-
lishing the phylogenetic relationships of R.
seeberi  to other eukaryotes. This approach is
based on amplification of the small subunit rRNA
gene sequence from infected tissue, as in the
method used to identify the culture-resistant
bacillus of Whipple disease (7). The sequence of
the small subunit rRNA gene has proven to be a
useful gauge of evolutionary relationships for many
organisms from diverse taxonomic groups (8).
Materials and Methods
Specimens
We obtained a sample of frozen, minced,
infected canine nasal polyp in tissue culture
media that had been used for the limited
propagation of R. seeberi in cell culture (6). After
thawing and a 1-minute centrifugation at 500 x g,
approximately 0.2 g of the tissue pellet was
digested by mechanical disruption and the DNA
was purified by adsorption to glass milk in the
presence of a chaotropic agent, according to the
manufacturer’s instructions (Fast Prep, Bio 101,
Vista, CA). The DNA was resuspended in 100 µL
of 10 mM Tris, 1 mM EDTA buffer at pH 8.5.
Three blocks of fixed, paraffin-embedded
nasal polyps from unrelated patients with
histologically confirmed rhinosporidiosis were
obtained. One tissue sample came from a patient
born in southern Asia but living in the United
States, and two samples came from patients
living in Spain. Twenty-three blocks of fixed,
paraffin-embedded nasal polyps from patients
without rhinosporidiosis were obtained from 12
consecutive patients at the Palo Alto Veterans
Affairs (VA) hospital who had undergone nasal
polypectomy. Two 25-µm sections were cut from
each block, and the sections were deparaffinized
and digested (5). DNA from the digests was then
purified by the Isoquick method (ORCA
Research, Inc., Bothell, WA), and the DNA was
resuspended in 25 µL of Tris/EDTA buffer.
Sections from a block of fixed, paraffin-embedded
human lymph node (histologically normal) were
also used in some experiments as negative
controls. Tissue sections of C. immitis in bone
were obtained from a patient with disseminated
coccidioidomycosis at the Palo Alto VA hospital
and used for fluorescence in situ hybridization
(FISH). Samples of Rosette agent and
Dermocystidium salmonis DNA were obtained
from the Bodega Marine Laboratory of the
University of California, Davis.
Fungal specimens in culture were obtained
from laboratories at Stanford University and the
Palo Alto VA Health Care System. A cotton swab
was used to transfer fungal cells from agar into a
1.5-mL microfuge tube containing 0.5 mL
digestion buffer (9) and 0.1 mL glass beads.
Samples were incubated at 55°C overnight, and
the proteinase k was inactivated at 95°C for 10
minutes and then subjected to two freeze-thaw
cycles by immersing tubes in a dry ice-
isopropranol bath followed by vortex mixing.
Consensus Polymerase Chain Reaction (PCR)
of the 18S rRNA Gene
Broad-range fungal PCR primers were
designed from a database of >4,000 small subunit
rDNA sequences, with the ARB software package
(Technical University, Munich, Germany). Prim-
ers were selected that would anneal to most
fungal and some protist 18S rDNA but not to 18S
rDNA from the chordata (F1-fw, F2-rev, F3-rev)
(Table). When the specificity of the primer pairs
was tested by using human lymphocyte DNA, no
amplification was observed (data not shown). The
broad range of primers F1-fw/F2-rev was tested
by using DNA from several diverse fungi.
Amplification products of the expected size were
produced by using DNA from Aspergillus oryzae,
Alternaria alternata, Candida albicans, Saccha-
romyces cerevisiae, Trichyphyton rubrum, Panus
rudis,  Neurospora crassa,  Fusarium solani,
Beauveria bassiana,  Flammulina velutipes,
Gibberella zeae, and Pleurotus ostreatus (data not
shown).
PCR consisted of 40 cycles of amplification on
a Perkin-Elmer GeneAmp 2400 thermal cycler.
After an initial activation of Taq gold at 94°C for
10 minutes, each cycle consisted of 30 seconds of
melting at 94°C, 30 seconds of annealing at 56°C,
and 30 seconds of extension at 72°C. The last
cycle was followed by an extension step at 72°C
for 7 minutes. Amplification products wereResear Resear Resear Resear Research ch ch ch ch
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Table. Polymerase chain reaction primers, sequencing primers, and fluorescence in situ hybridization probes
Primer/Probe Nucleotide sequence (5'->3') SSU rRNA Positiona







Rhino FISH probe BTGCTGATAGAGTCATTGAATTAACATCTACB
Control FISH probe BACGACTATCTCAGTAACTTAATTGTAGATGB
aSSU rRNA position based on S. cerevisiae 18S rRNA (GenBank J01353).
bfw = forward primer.
crev = reverse primer.
detected by electrophoresis on 2% agarose gels
stained with ethidium bromide and visualized
with a UV transilluminator.
On the basis of the sequences obtained by
consensus PCR with primers F1-fw/F2-rev (~500
bp) and F1-fw/F3-rev (~1000 bp), primers Dermo-
fw and Dermo-rev were designed (Table) and
used in a PCR to amplify a more complete 18S
rDNA sequence of R. seeberi.
Rhinosporidium-Specific PCR
A pair of PCR primers was designed from
unique regions of the R. seeberi 18S rRNA gene
sequence (Rhino-fw and Rhino-rev) (Table).
These primers were used in a 50-µL PCR as
described, except that AmpliTaq DNA poly-
merase (PE-ABI) was used at 1 unit per reaction,
no dimethyl sulfoxide was added, 50 cycles of
PCR were run with a 3-minute pre-melt at 94°C,
and the annealing temperature was 55°C. To
each 50-µL PCR reaction, 1 µL or 5 µL of purified
DNA were added.
ß-Globin PCR
ß-globin PCR was performed on control
tissues as described previously (9).
DNA Cloning, Sequencing,
and Phylogenetic Analysis
Amplification products were cloned by using
the Topo-TA cloning kit (Invitrogen, Carlsbad,
CA), and three clones were sequenced. Each clone
consisted of 1,750 bp of 18S rDNA. Priming
sequences were removed for further analysis,
yielding 1,699 bp of meaningful sequence. DNA
sequencing was performed as described (10). A
consensus sequence from the three clones was
made to correct for any Taq polymerase
incorporation errors. The 18S rDNA primers
(Table) were used as sequencing primers.
The  R. seeberi 18S rDNA sequence was
aligned by using the automated aligner of the
ARB software package. Ambiguously and
incorrectly aligned positions were manually
aligned on the basis of the conserved primary
sequence and secondary structure. The phyloge-
netic relationship of R. seeberi to other
eukaryotes was inferred from 1,350 unambigu-
ously aligned (masked) positions with a
maximum-likelihood algorithm (11,12), on the
basis of a previously aligned dataset of the DRIPs
clade (named after the organisms Dermocystidi-
um, the Rosette agent, Ichthyophonus, and
Psorospermium) (13). The dataset was used to
empirically determine nucleotide frequencies
and instantaneous substitution rates with the
restriction of a 2:1 transition to transversion
ratio. The organisms used in our tree and the
accession numbers for their small subunit rRNA
sequences include Artemia salina (X01723),
Xenopus laevis (X04025), Mytilus edulis (L24489),
Tripedalia cystophora (L10829), Microciona
prolifera (L10825), Diaphanoeca grandis (L10824),
Rosette agent (L29455), R. seeberi (AF158369),
Dermocystidium species (U21336), Dermocystid-
ium salmonis (U21337), Psorospermium haeckelii
(U33180), Ichthyophonus hoferi (D14358), As-
pergillus fumagatus (M60300), Chytridium
confervae (M59758), Mucor racemosus (X54863),
Acanthamoeba castellanii (U07413), Zamia
pumila (M20017), Porphyra spiralis (L26177),
Lagenidium giganteum (X54266), Labyrinthu-
loides minuta (L27634), Perkinsus marinus
(X75762), Sarcocystis muris (M64244). The treeResear Resear Resear Resear Research ch ch ch ch
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topology was confirmed by using a neighbor-
joining algorithm with Jukes-Cantor corrected
distance values and a maximum-parsimony
algorithm (ARB). The nucleotide sequence for the
partial 18S rRNA gene of R. seeberi has been
deposited in GenBank (accession number
AF158369).
Fluorescence in Situ Hybridization (FISH)
Tissue sections on slides were dewaxed by
immersion in 99% octane (Sigma, St. Louis, MO).
Samples subjected to FISH included R. seeberi–
infected human nasal polyps, C. immitis–infected
bone, a Rosette agent–infected cell line, and
smears of C. albicans. The Rhinosporidium probe
was based on the Rhino-rev 18S rDNA primer
and was biotinylated at both the 5' and 3' ends
(Table). The control probe, which consisted of the
complement of the Rhinosporidium probe, was
also biotinylated at both ends. To each slide, 50
ng of biotinylated probe in 30 µL of hybridization
buffer was added. Cover slips were placed, and
the slides were incubated at 40°C overnight in a
humid chamber. The hybridization buffer
consisted of 10% dextran, 0.2% bovine serum
albumin, and 0.01% polyadenosine, in 5X SET
buffer; the 25X SET buffer consisted of 3.75M
sodium chloride, 25 mM EDTA, and 0.5M Tris at
pH 7.8. Cover slips were removed by immersion
in 5X SET buffer at 4°C, and the slides were
washed for 10 minutes per cycle, twice in 0.2X
SET buffer at 25°C and once at 40°C. The slides
were then subjected to tyramide signal amplifica-
tion according to the manufacturer’s instructions
(TSA indirect, NEN Life Sciences, Boston, MA).
Cy5-streptavidin (Amersham, Piscataway, NJ)
at 1 mg/mL was diluted 1:500 and added to the
slides for fluorescence signal detection. Tissue
sections were visualized on a Bio-Rad confocal
microscope at 200X magnification after the
application of 15-20 µL of Vectashield mountant
(Sigma) and a cover slip.
Electron Microscopy
A portion of formalin-fixed, paraffin-embed-
ded nasal polyp from a patient with rhinosporidi-
osis was removed from the block, dewaxed with
xylene, rehydrated with ethanol, post-stained
with 1.5% osmium tetroxide, then dehydrated
with ethanol, transferred to propylene oxide
followed by Epon 12 resin, heat-catalyzed at
65°C, and ultrasectioned at 50 nm. The grid-
mounted sections were then serially stained with
lead hydroxide and uranyl acetate and examined
with a Phillips 201 electron microscope at 75KV.
Results
Phylogenetic Classification of R. seeberi
Inferred from the 18S rRNA Gene
Consensus PCR of the 18S rRNA gene with
DNA from a digest of an R. seeberi–infected
canine nasal polyp produced amplification products
of the expected size visible on gel electrophoresis
(primer pairs F1-fw/F2-rev = ~500 bp and F1-fw/
F3-rev = ~1000 bp) (data not shown). No
amplification product was detected by using
control tissue and reagents. On the basis of the
initial phylogenetic assessment of these se-
quences, primers Dermo-fw and Dermo-rev were
designed for amplification of a more complete
portion of the R. seeberi 18S rRNA gene. Our
phylogenetic analysis of this gene suggests that
R. seeberi is a member of the DRIPs clade of
aquatic protistan parasites (Figure 2). The
nearest evolutionary neighbors of R. seeberi for
which a sequence is available are members of
the  Dermocystidium genus, which infect
salmon and trout.
Development and Use of a
Rhinosporidium-Specific PCR Assay
A PCR assay specific for R. seeberi was
developed. Primers were created by aligning 18S
rDNA sequences from R. seeberi, members of the
DRIPs clade, Saccharomyces cerevisiae, and
humans. The Rhinosporidium primers (Rhino-
fw, Rhino-rev) each have three nucleotide
mismatches with the sequences from the nearest
phylogenetic relatives in the Dermocystidium
genus and multiple other mismatches with
fungal and human 18S rDNA sequences. An
assay sensitivity of 1-10 gene copies was
demonstrated by using a dilution series of cloned
R. seeberi 18S rDNA. The specificity of the assay
was assessed with DNA from human lympho-
cytes, S. cerevisiae, D. salmonis, and the Rosette
agent. No amplification was detected when these
DNA samples were used in the specific PCR
assay, although product was amplified from
these samples with either ß-globin primers
(lymphocytes) or broad-range 18S rDNA primers
(F1-fw/F2-rev) (Table).
The original DNA sample from the infected
canine nasal polyp yielded a visible product of the
expected size with the Rhinosporidium-specificResear Resear Resear Resear Research ch ch ch ch
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Figure 2. Phylogeny of Rhinospo-
ridium seeberi and the DRIPs clade
of protists (Ichthyosporea). A. Phy-
logenetic tree inferred from the 18S
rDNA sequences of R. seeberi and
other selected eukaryotes by using a
maximum likelihood algorithm;
1,350 masked positions were used
for analysis. Bootstrap values were
generated from 100 resamplings.
The bar, which represents 0.1 base
changes per nucleotide position, is a
measure of evolutionary distance. B.
Phylogenetic tree using the data
from A, but with pruning and
grouping to show the broader
evolutionary position of the DRIPs
clade.
A
BResear Resear Resear Resear Research ch ch ch ch
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Figure 3. Agarose gel electrophoresis of Rhinospo-
ridium-specific PCR products. The specific amplifica-
tion product is 377 bp. No amplification product is
seen in the negative control samples consisting of
water (reagent-only control), digestion buffer (DB), or
lymph node tissue control (Tis Cnt). The human
rhinosporidiosis samples (RS1-3) and the original
canine nasal polyp show visible amplification
products.
PCR assay (Figure 3). Purified DNA from the
tissue blocks of human nasal polyps resected
from three patients with rhinosporidiosis also
yielded positive results in this PCR assay, with
visible bands seen on gel electrophoresis (RS 1-3)
(Figure 3). Direct sequencing of these PCR
products demonstrated complete identity over
the 377 bp with the cloned sequence from the
canine polyp. DNA samples from 23 nasal polyp
specimens resected from 12 patients without
rhinosporidiosis were subjected to both Rhino-
sporidium-specific and ß-globin PCR assays.
These uninfected polyps failed to yield visible
amplicons after gel electrophoresis of the
Rhinosporidium-specific PCR reactions (data not
shown). However, all these samples yielded
amplification products after ß-globin PCR,
demonstrating that amplifiable DNA was
present, without substantial PCR inhibition.
These results confirmed that the presence of the
putative  R. seeberi 18S rDNA sequence
correlated with the presence of disease
(rhinosporidiosis).
Fluorescence in Situ Hybridization
We sought to determine by using FISH if the
R. seeberi 18S rDNA sequence was linked to
visible pathology in tissue. The Rhinosporidium
18S rRNA probe but not the control probe bound
to  R. seeberi organisms in tissue, providing
further evidence that the putative R. seeberi 18S
rRNA sequence is present in R. seeberi organisms
(Figure 4). To test the specificity of the
hybridization, smears of the fungus C. albicans,
cells infected with the Rosette agent, and tissue
sections of C. immitis were subjected to FISH. No
specific hybridization to these organisms was
detected by using the Rhinosporidium 18S rRNA
probe compared with the control probe (data not
shown).
Electron Microscopy
Transmission electron micrographs were
taken of R. seeberi trophocytes in a human nasal
polyp. Multiple mitochondria were visualized,
showing that the cristae had tubulovesicular
morphology (Figure 5), unlike the flat cristae
found in fungi.
Discussion
In the 1890s, first Malbran and then
Seeber (14) described an apparent sporozoan
parasite in nasal polyps from patients living in
Argentina. Seeber’s teacher, Wernicke, named
the organism Coccidium seeberia after the
protozoal subdivision Coccidia and his pupil,
Guillermo Seeber (2). In 1923, Ashworth
described the life cycle of the organism, argued
that it is a fungus, and proposed the name
R. seeberi (15). Since then, the microbe has been
considered a fungus by most microbiologists,
although its taxonomy has been debated (1,2,16).
Using a consensus PCR approach, we amplified a
unique 18S rDNA sequence from a canine nasal
polyp infected with R. seeberi. To prove that this
unique 18S rDNA sequence came from R. seeberi,
we sought to fulfill sequence-based guidelines for
microbial disease causation, since Koch’s postu-
lates cannot be fulfilled for uncultivated
microbes (17). Using a Rhinosporidium-specific
PCR assay, we showed that the unique rDNA
sequence present in the canine polyp was also
present in three human polyp samples from
patients with rhinosporidiosis. We showed theResear Resear Resear Resear Research ch ch ch ch
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Figure 4. An oligonucleotide probe complementary to a unique region of the Rhinosporidium seeberi 18S rRNA
sequence localizes to visible organisms in human nasal tissue by using fluorescence in situ hybridization.
Confocal micrographs at 200X magnification. The Cy-5-labeled Rhinosporidium probe (blue) hybridizes to
spherical R. seeberi trophocytes (A) and a sporangium with endospores (B). A control probe consisting of the
complement of the Rhinosporidium probe labeled with Cy-5 does not hybridize to the trophocytes (C) or a
sporangium with endospores (D). Images were collected in two wave-length channels: the first for Texas Red (red)
or FITC (green) displays tissue architecture through autofluorescence, and the second channel for Cy-5 (blue
pseudocolor) displays the probe signal.
A B
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Figure 5. Transmission electron micrograph of a
mitochondrion from Rhinosporidium seeberi. The
cristae of this mitochondrion (arrows) have
tubulovesicular morphology. Magnification 195,000X.
specificity of this association by demonstrating
that this rDNA sequence was not present in
control nasal polyps from 12 patients without
rhinosporidiosis. We also used FISH to link the
putative  R. seeberi 18S rRNA sequence to
organisms visible in tissue. Although the
Rhinosporidium probe localized to R. seeberi
organisms in tissue using FISH, the probe did not
localize to two fungal organisms or another
member of the DRIPs clade (Rosette agent),
suggesting some specificity to the hybridization.
Sequence-based data also provide support for
a causal relationship when a microbial genotype
(e.g., phylogenetic placement) correctly predicts
microbial phenotype and host response (17). In
other words, the nature of the pathogen inferred
from phylogenetic analysis of its nucleic acid
sequence should be consistent with the known
biologic characteristics of closely related mi-
crobes and with the nature of the disease.
Therefore, the nearest phylogenetic neighbors to
R. seeberi could be predicted to have similarities
in morphology, tissue histology, and pathogen-
esis. D. salmonis, the closest known relative to
R. seeberi, has a large spherical structure
containing endospore-like daughter cells (18).
Histology of infected hosts shows gill inflamma-
tion and epithelial hyperplasia. The resemblance
between R. seeberi and fish pathogens has been
noted before. In 1960, Satyanarayana wrote in
his review of 255 cases of rhinosporidiosis (1) that
since R. seeberi has a morphology similar to those
of some fish parasites, it “..may also be a parasite
or saprophyte of fish and that man, equines, and
cattle obtain the infection through water in which
fish harbouring the parasite live.”
A recent independent report based on
amplification of 18S rDNA from two human
rhinosporidiosis tissue samples also concludes
that R. seeberi is a member of the DRIPs clade of
microbes (19). Our data support this conclusion
and provide more evidence for a causal
relationship. In addition, we describe a Rhino-
sporidium-specific PCR assay that can be used
for detecting this organism in clinical and
environmental samples. Our 18S rDNA sequence
differs from the sequence determined by these
investigators (GenBank AF118851) at a single
position out of 1,699 common bases. We excluded
from analysis sequence derived from our PCR
primers, as amplicons will contain the primer
sequences regardless of the target sequence as
long as there is partial annealing during PCR,
leading to potentially spurious conclusions about
sequence in these regions. The 18S rDNA
sequence of R. seeberi determined by this group
includes the primer sequences.
Although we describe early trophocytes with
mitochondrial cristae having vesicular ultra-
structure, other investigators have found sporan-
gia with mitochondrial cristae having a flat
ultrastructure (19). The different mitochondrial
morphologies observed may be due to differences
in developmental stage of the organism or in
methods of tissue preparation for electron
microscopy. Nevertheless, another member of
the DRIPs clade, Ichthyophonus hoferi, has
vesicular mitochondrial cristae. Classic fungi
(Eumycota) have flat mitochondrial cristae.
Knowledge of the molecular phylogeny of
R. seeberi is more than an exercise in taxonomy.
For organisms such as R. seeberi, which are
difficult to grow in the laboratory, phylogenetic
analysis provides some insight into the charac-
teristics of the organism that can be used to
further our understanding of disease pathogen-
esis and epidemiology, as well as to improve
diagnosis and treatment. Knowing that R. seeberi
is a member of the DRIPs clade of microbes allows
hypotheses to be generated about how it causes
human disease by analogy, drawing on the
knowledge and experience of the veterinary
sciences. The separate but linked observations
that rhinosporidiosis in humans is associated
with exposure to water and that R. seeberiResear Resear Resear Resear Research ch ch ch ch
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belongs to a clade of aquatic parasites lead to a
testable hypothesis: the natural hosts of
R. seeberi are fish or other aquatic animals, and
humans acquire infection when they come into
contact with water containing these fish and
their parasites. Investigators should therefore
look for evidence of infection in fish in ponds and
rivers in disease-endemic areas. From a public
health perspective, the R. seeberi–specific PCR
assay can be used to study environmental sources
of infection (e.g., specific bodies of water) and
may provide a means of preventing disease
through identification of infected water.
Conversely, knowing that R. seeberi is a
member of the DRIPs clade may help us
understand this important, distinct group of
microbes that appear to form the deepest branch
in the animal lineage. R. seeberi is a member of a
newly recognized group of human and animal
pathogens; the name Ichthyosporea has been
proposed for this expanding taxon of microbes
(20). Little information is available about these
organisms and how they cause disease. We hope
that collaborations between researchers in
human and animal medicine will correct this
deficiency.
Multiple antimicrobials, including antifun-
gal agents, have been used in the treatment of
rhinosporidiosis, based on the belief that
R. seeberi is a fungus. However, no antimicrobial
agent is clearly effective. The medical treatment
of rhinosporidiosis may be improved through
screening antiparasitic drugs for an effect on
disease in Dermocystidium-infected fish or
infected cell lines.
In conclusion, phylogenetic analysis of the
R. seeberi 18S rRNA gene suggests that this
culture-resistant organism is not a member of the
Eumycota, but rather is the first known human
pathogen from a novel clade of aquatic protistan
parasites that form a branch in the evolutionary
tree near the animal-fungal divergence. R. seeberi-
specific PCR and FISH confirm the association of
this unique 18S rDNA sequence with the
presence of rhinosporidiosis. This knowledge can
be used to further our understanding of the
natural reservoir of this organism and the risk
factors, pathogenesis, and treatment of this
disease. This discovery also expands our
appreciation of the diversity among eukaryotic
organisms that are pathogenic to humans and
highlights the limitations of basing phylogenetic
classification on morphology alone.
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